Oxbow Advisors, LLC Astrazeneca PLC Transaction History
Oxbow Advisors, LLC
- $706 Million
- Q4 2024
A detailed history of Oxbow Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Oxbow Advisors, LLC holds 37,343 shares of AZN stock, worth $2.91 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
37,343
Previous 2,958
1162.44%
Holding current value
$2.91 Million
Previous $230,000
963.48%
% of portfolio
0.35%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.71 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.2 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.92 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.89 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.87 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...